Skip to content

Neurologic uses of botulinum neurotoxin type A

by John P. Ney, Kevin R. Joseph
Neuropsychiatric Disease and Treatment ()

Abstract

This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical mechanism at the neuromuscular junction. Current commercial preparations of BoNT-A are reviewed, as are immunologic issues relating to secondary failure of BoNT-A therapy. Clinical uses are summarized with an emphasis on controlled clinical trials (as appropriate), including facial movement disorders, focal neck and limb dystonias, spasticity, hypersecretory syndromes, and pain.

Cite this document (BETA)

Readership Statistics

30 Readers on Mendeley
by Discipline
 
57% Medicine and Dentistry
 
27% Agricultural and Biological Sciences
 
7% Psychology
by Academic Status
 
23% Student > Master
 
17% Student > Bachelor
 
13% Lecturer
by Country
 
3% United Kingdom
 
3% Brazil
 
3% United States

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in